Clinical Trials Search at Vanderbilt-Ingram Cancer Center

ANBL2131: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma

Disease Sites: Not Available

Phase: III

Investigator: Benedetti, Daniel

NCTID: NCT06172296

Protocol No: VICC-NTPED24104

A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma.

Pediatrics

Disease Sites: Pediatrics

Phase: III

Investigator: Borinstein, Scott

NCTID: NCT05304585

Protocol No: COGARST2032

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form